Surgical and Medical Treatment of Secondary Hyperparathyroidism in Patients on Continuous Dialysis

被引：0
|
作者：
Yoshihiro Tominaga
Susumu Matsuoka
Nobuaki Uno
机构：
[1] Nagoya Second Red Cross Hospital,Department of Transplant and Endocrine Surgery
来源：
World Journal of Surgery | 2009年 / 33卷
关键词：
Parathyroid Gland; Cinacalcet; Parathyroid Carcinoma; Parathyroid Tissue; Calciphylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2335 / 2342
页数：7
相关论文
共 50 条
  • [41] Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the treatment response of dialysis patients with secondary hyperparathyroidism
    de Alarcon, Rosa
    Alburquerque-Gonzalez, Begona
    Fernandez-Valera, Africa
    Molina-Nunez, Manuel
    Alvarez Fernandez, Gracia
    Consuegra-Sanchez, Luciano
    Luengo-Gil, Gines
    Conesa-Zamora, Pablo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (04) : 792 - 795
  • [42] Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients
    Lee, Yueh-Ting
    Ng, Hwee-Yeong
    Kuo, Chien-Chun
    Chen, Te-Chuan
    Wu, Chien-Shing
    Chiu, Terry Ting-Yu
    Lee, Wen-Chin
    Lee, Chien-Te
    NUTRIENTS, 2013, 5 (04): : 1336 - 1348
  • [43] A new paradigm for the treatment of secondary hyperparathyroidism
    de Francisco, Angel L. M.
    Carrera, Fernando
    CLINICAL KIDNEY JOURNAL, 2008, 1 : I24 - I28
  • [44] Advances in the treatment of secondary and tertiary hyperparathyroidism
    Zhang, Li-Xi
    Zhang, Ben
    Liu, Xu-Yao
    Wang, Zi-Ming
    Qi, Peng
    Zhang, Tong-Yue
    Zhang, Qiang
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [45] Decreasing Surgical Management of Secondary Hyperparathyroidism in the United States
    Fligor, Scott C.
    Li, Chun
    Hamaguchi, Ryoko
    William, Jeffrey
    James, Benjamin C.
    JOURNAL OF SURGICAL RESEARCH, 2021, 264 : 444 - 453
  • [46] Denosumab Decreases Epicardial Adipose Tissue Attenuation in Dialysis Patients with Secondary Hyperparathyroidism and Low Bone Mass
    Chen, Chien-Liang
    Liou, En-Shao
    Wu, Ming-Ting
    CARDIORENAL MEDICINE, 2024, 14 (01) : 113 - 122
  • [47] Is cinacalcet a cost-effective treatment in severe secondary hyperparathyroidism in patients on hemodialysis?
    Arenas, M. D.
    Rebollo, P.
    Alvarez-Ude, F.
    Prieto, L.
    Gil, M. T.
    Malek, T.
    Moledous, A.
    Nunez, C.
    NEFROLOGIA, 2008, 28 (05): : 511 - 516
  • [48] Real world evaluation of etelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients in Argentina
    Wojtowicz, Daniela
    Laham, Gustavo
    Forrester, Mariano
    del Valle, Elisa
    Penalba, Adriana
    Filannino, Graciela
    Sammartino, Andrea
    Mengarelli, Cecilia
    Rosa-Diez, Guillermo
    Negri, Armando Luis
    THERAPEUTIC APHERESIS AND DIALYSIS, 2024,
  • [49] Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism
    Kuczera, Piotr
    Adamczak, Marcin
    Wiecek, Andrzej
    BMC NEPHROLOGY, 2016, 17 : 1 - 7
  • [50] Treatment Based on Cinacalcet Reduces Oxidative Stress in Hemodialysis Patients with Secondary Hyperparathyroidism
    Kuczera, Piotr
    Adamczak, Marcin
    Machnik, Grzegorz
    Okopien, Boguslaw
    Wiecek, Andrzej
    NEPHRON, 2018, 139 (04) : 286 - 292
12345